PM

Prosight Management Portfolio holdings

AUM $610M
1-Year Est. Return 40.86%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+40.86%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$610M
AUM Growth
+$126M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
54
New
Increased
Reduced
Closed

Top Buys

1
+$46.8M
2
+$42.7M
3
+$20M
4
ALKS icon
Alkermes
ALKS
+$15.9M
5
PRCT icon
Procept Biorobotics
PRCT
+$15.9M

Top Sells

1
+$20M
2
+$16.4M
3
+$15.4M
4
ROIV icon
Roivant Sciences
ROIV
+$11.5M
5
AVTR icon
Avantor
AVTR
+$10.3M

Sector Composition

1 Healthcare 99.84%
2 Industrials 0.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KIDS icon
26
OrthoPediatrics
KIDS
$441M
$4.8M 0.79%
302,399
+165,658
IMVT icon
27
Immunovant
IMVT
$6.84B
$4.37M 0.72%
175,825
-67,579
ICUI icon
28
ICU Medical
ICUI
$3.38B
$3.55M 0.58%
+27,450
TECX
29
Tectonic Therapeutic
TECX
$588M
$2.47M 0.4%
79,872
-155,128
RCKT icon
30
Rocket Pharmaceuticals
RCKT
$335M
$2.45M 0.4%
683,856
-60,086
UPB
31
Upstream Bio Inc
UPB
$455M
$2.17M 0.36%
+241,123
PLRX icon
32
Pliant Therapeutics
PLRX
$78M
$2.1M 0.34%
1,667,600
+111,856
OMER icon
33
Omeros
OMER
$799M
$1.85M 0.3%
+174,800
ISRG icon
34
Intuitive Surgical
ISRG
$150B
$1.84M 0.3%
+4,000
ANTX icon
35
AN2 Therapeutics
ANTX
$156M
$1.76M 0.29%
+515,754
ACET icon
36
Adicet Bio
ACET
$87M
$1.7M 0.28%
250,244
RGNX icon
37
Regenxbio
RGNX
$362M
$1.68M 0.27%
+200,000
COYA icon
38
Coya Therapeutics
COYA
$113M
$1.66M 0.27%
+420,360
VKTX icon
39
Viking Therapeutics
VKTX
$3.8B
$1.46M 0.24%
+45,000
IRTC icon
40
iRhythm Holdings
IRTC
$3.74B
$1.18M 0.19%
+10,000
TBI
41
Trueblue
TBI
$189M
$974K 0.16%
249,107
-193,447
IMRX icon
42
Immuneering
IMRX
$373M
$650K 0.11%
+123,409
PVLA
43
Palvella Therapeutics
PVLA
$1.7B
$623K 0.1%
+5,000
NVCR icon
44
NovoCure
NVCR
$1.97B
$549K 0.09%
+50,400
RNTX
45
Rein Therapeutics
RNTX
$94.9M
$535K 0.09%
411,600
-31,000
TMDX icon
46
Transmedics
TMDX
$2.32B
$497K 0.08%
+5,000
AVTR icon
47
Avantor
AVTR
$6.23B
– –
-898,499
BBIO icon
48
BridgeBio Pharma
BBIO
$13B
– –
-30,000
CDNA icon
49
CareDx
CDNA
$1.18B
– –
-250,000
FOLD
50
DELISTED
Amicus Therapeutics
FOLD
– –
-1,150,000
1
2
3